Skip to main content

News

All the latest news and information on the main advances in research, institutional milestones, teaching and management. Find out what happens at the Vall d'Hebron Research Institute!

The HepClink project, started in 2019, has been effective in reaching an immigrant population with low knowledge of the disease and that, in general, has not been tested before

 

Es tracta d'un projecte pioner a l'Estat que ha permès detectar més de 128 persones amb el virus actiu, de les quals 40 han estat tractades i curades.

Vall d'Hebron is one of the participants in the CARB-ES-19 research, led by the CIBER, in which 71 hospitals throughout the peninsula have collaborated.

The researcher Carles Rubio presented the research of the VHIR Microbiology research group and the UPC and co-funded by the Probitas Foundation.

Dr. Luz Uria was recognized for the best communication of the Congress of the Sociedad Española de Hematología y Oncología Pediátrica, the second place was for Dr. Raquel Hladun.

The first global study on the prevalence of functional gastrointestinal disorders has been the most successful article.

 

 

Es va reconèixer la tasca de més de 70 professionals dedicades a aquesta malaltia pulmonar, tant assistencial com de recerca.

The meeting allows establishing the basis for collaboration between experts from around the world, with the aim of promoting research on this protein and its role in cancer.

In pediatric cancers, sarcomas account for 14% of cases and 20% of deaths.

On the 2nd and 3rd of June, the European University Hospital Alliance (EUHA) celebrated its 5th anniversary with a symposium at University Hospitals Leuven.

Manina Medtech received a direct grant of 75,000 euros from the ACCIÓ Startup Capital line, aimed at boosting the growth of emerging companies with high technological potential.

This award is given to people and organisations in recognition of outstanding contributions to the development of science and technology in Catalonia.

The drug EB1 is able to block resistance pathways to standard cancer treatments and could increase the efficacy of chemotherapy or immunotherapy.

EJP RD announces the release of the Innovation Management Toolbox (IMT), a tool created to provide self-help resources specific to the needs of researchers in this type of pathologies.

The research led by Dr. José Alegre has been one of the 21 projects selected in the 19th call for Health Research Grants.

We present VHIR's annual commitment to communicate the scientific and institutional results of 2021 with a renewed format and design.

La Recuperació Intensificada en Cirurgia aconsegueix que el procés perioperatori de les pacients de ginecologia oncològica millori, escurçant l'estada hospitalària, els reingressos, les complicacions postoperatòries i el confort de les pacients.

Ana Sánchez és investigadora predoctoral del grup Diagnostic Nanotools del VHIR i la seva tesi es centra en l’ús de cèl·lules sintètiques per millorar el control de pandèmies de grip.

The research led by Vall d'Hebron is a breakthrough in the search for specific and effective treatments for the disease.

La primera jornada dedicada a aquesta malaltia organitzada pel Campus Vall d’Hebron ha reunit més de 150 assistents.

The article on the mortality rate of young people with HIV due to perinatal transmission after transitioning to adult health care in Spain received the PIDJ award.

The study conducted at Vall d'Hebron shows that having a high level of neurofilament light chains translates, over the years, to a higher level of disability.

Vall d'Hebron és referent en el diagnòstic i abordatge multidisciplinari de l’esteatohepatitis no alcohòlica i liderem el nombre d’assajos clínics a l’Estat sobre NASH.

Researchers have generated a female and male pig model of ischemia/reperfusion renal injury and organ regeneration to study sex differences.